ASX - By Stock
|
GBE |
Re:
Countdown MDA
|
|
Colingray
|
494 |
108K |
4 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
494
|
108K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
11 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
13K
|
6.4M
|
11
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Colingray
|
368 |
121K |
4 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
368
|
121K
|
4
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Colingray
|
368 |
121K |
14 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
368
|
121K
|
14
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Colingray
|
368 |
121K |
4 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
368
|
121K
|
4
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Colingray
|
368 |
121K |
24 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
368
|
121K
|
24
|
|
ASX - By Stock
|
BIT |
Re:
“…BIT225 showed no antiviral activity…”
|
|
Colingray
|
29 |
11K |
12 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
29
|
11K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
2 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
221
|
59K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
10 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
221
|
59K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
13 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
221
|
59K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
22 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
221
|
59K
|
22
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
13 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
221
|
59K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
8 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
221
|
59K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
5 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
221
|
59K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Colingray
|
3.2K |
1.0M |
3 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
19 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
221
|
59K
|
19
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
21 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
221
|
59K
|
21
|
|
ASX - By Stock
|
BIT |
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Colingray
|
221 |
59K |
35 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
221
|
59K
|
35
|
|
ASX - By Stock
|
BIT |
Covid-19 - A potent version of airborne HIV?
|
|
Colingray
|
4 |
2.5K |
35 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
4
|
2.5K
|
35
|
|
ASX - By Stock
|
BIT |
Re:
E Protien of Corona Virus
|
|
Colingray
|
32 |
12K |
8 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
32
|
12K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
E Protien of Corona Virus
|
|
Colingray
|
32 |
12K |
9 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
32
|
12K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
12 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
12
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
20 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
20
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
5 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
10 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
10
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
7 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
11 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
11
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
9 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
13K
|
6.4M
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Colingray
|
440 |
143K |
6 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
440
|
143K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Colingray
|
440 |
143K |
17 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
440
|
143K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Trading Halt
|
|
Colingray
|
387 |
154K |
27 |
06/09/20 |
06/09/20 |
ASX - By Stock
|
387
|
154K
|
27
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Checklist of Future Announcements post Sept 2020
|
|
Colingray
|
80 |
27K |
24 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
80
|
27K
|
24
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Pause in Trading
|
|
Colingray
|
252 |
96K |
13 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
252
|
96K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Pause in Trading
|
|
Colingray
|
252 |
96K |
7 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
252
|
96K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Colingray
|
2.0K |
740K |
11 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
2.0K
|
740K
|
11
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
9 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
9
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Colingray
|
2.0K |
740K |
13 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
2.0K
|
740K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Colingray
|
2.0K |
740K |
8 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
2.0K
|
740K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Colingray
|
2.0K |
740K |
12 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
2.0K
|
740K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Colingray
|
2.0K |
740K |
16 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
2.0K
|
740K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Colingray
|
3.2K |
1.0M |
11 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
11
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
13 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
13
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Colingray
|
3.2K |
1.0M |
14 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
14
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Colingray
|
3.2K |
1.0M |
6 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
21 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
21
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
8 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
15 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
15
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
19 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
19
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Colingray
|
13K |
6.4M |
44 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
13K
|
6.4M
|
44
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Colingray
|
2.0K |
740K |
3 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
2.0K
|
740K
|
3
|
|